HLS Therapeutics Inc. HLTRF
2.60 USD -0.13 (-4.76%)
Regular-session close
2.46 Day range 2.60
2.46 52-week range 3.47
- YTD
- -24.20%
- 1 year
- -26.55%
News
marketbeat.com What HLS Therapeutics (HLS) Said on Its Q3 Earnings Call HLS Therapeutics TSE: HLS reported higher third-quarter revenue as growth in its cardiovascular portfolio offset a decline in Canadian Clozaril sales, and said it expects revenue and adjusted EBITDA…
seekingalpha.com HLS Therapeutics Inc. (HLS:CA) Q3 2026 Earnings Call Transcript HLS Therapeutics Inc. (HLS:CA) Q3 2026 Earnings Call Transcript
